Table 1. IC50 values (mean±SD, n=3) in cell lines measured via SRB assay.
| Cell type | Cell lines | Neochamaejasmin C IC50 (μmol/L) | Chamaejasmenin B IC50 (μmol/L) | Paclitaxel IC50 (μmol/L) |
|---|---|---|---|---|
| Human liver carcinoma | SMMC-7721 | 9.28±3.69 | 7.22±3.33 | 14.32±1.68 |
| Human liver carcinoma | HepG2 | 3.75±1.19 | 1.26±0.46 | 5.33±2.45 |
| Human non-small cell lung carcinoma | A549 | 5.72±2.37 | 1.08±0.40 | 7.33±2.46 |
| Human osteosarcoma | MG63 | 7.37±2.10 | 3.67±1.39 | 4.38±2.01 |
| Human osteosarcoma | U2OS | 8.76±1.84 | 7.82±2.06 | 10.41±2.31 |
| Human osteosarcoma | KHOS | 3.07±0.49 | 1.56±0.44 | 1.45±1.27 |
| Human colonic carcinoma | HCT-116 | 15.97±1.93 | 10.80±3.07 | 4.78±1.13 |
| Human cervical carcinoma | HeLa | 10.06±1.89 | 7.02±1.40 | 1.85±0.40 |